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Abstract
The extent of latent HIV-1 infection in blood T cells and mono-
cytes of 23 seropositive individuals was examined using DNA
amplification (PCR) of HIV-1 sequences. Amplified DNAwas
found in at least one cell type in all seropositives tested, includ-
ing 13 asymptomatic, 5 ARC, and 5 AIDS patients. Amplifica-
tion with two or more primer sets from the gag, enm, LTR oc-
curred in 21 (91%) patients' T cells and 17 (74%) patients'
monocytes. However, amplification with the LTR primers in
monocytes was uncommon.
Among four patients tested, amplified DNAcontinued to be
detected after a greater than one thousand-fold dilution (< 500
cells) of both T cell and monocyte lysates. Repeat analysis after
7-9 mo in five seropositives yielded similar findings in T cells
and monocytes, but some variation in the efficacy of amplifica-
tion with individual primers occurred. There was no difference
in those 10 patients who were taking AZT, compared to those
who were untreated.
Our results indicate that a fraction (< 1%) of both T cells
and monocytes in blood carry a latent infection in all stages of
HIV-1 disease and can serve as reservoirs throughout AZT
therapy. (J. Clin. Invest. 1991. 87:27-30.) Key words: HIV-1-
monocyte * T cell
Introduction
The ability of human immunodeficiency virus type- 1 (HIV- 1)
to establish a latent infection in blood cells contributes to the
spread of virus to multiple tissues and between individuals.
Recent reports indicate that a greater burden of both cell-asso-
ciated and cell-free HIV- I can be detected in the blood of sero-
positive individuals than previously recognized (1, 2). The evi-
dence from these studies is based upon measurement of HIV- I
production in a tissue culture system. Application of the poly-
merase chain reaction (PCR)', which can amplify one to a few
copies of the HIV-l genome within host cell DNA(3, 4), per-
mits a more direct and sensitive examination of the extent of
latent infection, and in different cell types.
Using PCR, a recent study of AIDS patients reported that
CD4+T cells, but not monocytes, were the major reservoir for
Address reprint requests to Dr. M. Juliana McElrath, Box 280, The
Rockefeller University, 1230 York Ave., NewYork, NY 10021.
Receivedfor publication 13 March 1990 and in revisedform 1 7May
1990.
1. Abbreviations used in this paper: ARC, AIDS-related complex; ASX,
no symptoms; PCR, polymerase chain reaction.
latent HIV- 1 infection (5). Weindependently have surveyed
monocytes and T cells from seropositive individuals who have
AIDS, AIDS-related complex (ARC), or no symptoms (ASX)
using the PCRmethod. Our results confirm that some T cells
carry a latent infection in all stages of disease. However, we also
detect HIV- 1 DNAin enriched populations of monocytes,
even though productive infection may be difficult to elicit from
this cell population (6).
Methods
Venipuncture was performed on 23 HIV-I seropositive participants in
a longitudinal HIV study at the Rockefeller University Hospital. The
70- 100 ml of heparinized blood was distributed for complete blood cell
counts, CD4/CD8 T cell analysis, and cell separation. Blood from
known low risk seronegatives was obtained concomitantly to serve as
controls.
Cell separation. As previously described (7), blood mononuclear
cells were obtained from the interface of Ficoll-Paque gradients and
incubated with neuraminidase-treated sheep red blood cells at 4VC for
I h. T cells, which form rosettes with the red cells, were separated from
other mononuclear cells by a second Ficoll-Paque gradient. Contami-
nating Fc receptor-bearing monocytes were removed from the T cell
population by panning on bacteriologic petri dishes coated with puri-
fied human gamma-globulin (CooperBiomedical, Inc., West Chester,
PA) (7) or by adherence onto plastic dishes for I h at 370C.
To obtain monocytes, the T cell-depleted (nonrosetting) cells were
cultured in Teflon beakers for < 36 h and then adhered I h onto plastic
dishes. By culturing the cells before the adherence step we avoided
contaminating dendritic cells and B cells which are loosely adherent
immediately upon isolation but much less so after culture. The adher-
ent cells were washed, incubated 15 min in 3 mMEDTAat 370C, and
gently pipetted or scraped from the plastic. CD4' or CD8+T cells were
not detectable by FACScan flow cytometry (6).
Preparation of DNA lysates. Purified monocytes or T cells were
washed twice with PBS, resuspended at 107 cells per ml of lysis buffer
(10 mMTris-HCI, pH 8.0, 1 mMEDTA, 0.001% Triton X-100,
0.0001% SDS, and 600 Mg/ml proteinase K) (Boehringer Mannheim
Biochemicals, Indianapolis, IN), and digested I h in a 600C waterbath.
The proteinase K then was inactivated at 95°C for 15 min. Lysates
were stored at -20°C until use in the PCRreaction.
DNAamplification. Wechose three oligonucleotide primer pairs to
amplify HIV-1 sequences from conserved regions of the genome:
SK38/39, from a 1 14-bp region of gag (1551-1578 and 1638-1665);
SK29/30, from a 104-bp region of LTR (501-518; and SK68/69, from
a 141 -bp region of env (7801-7829 and 7922-7942) (4). Each tube for
PCRcontained (delivered in the following order) 50 MI mineral oil, 50
Ml primer reaction mixture (see below), and 50 Ml DNAlysate (contain-
ing 5 x 105 cells or - I 1Mg DNA). Primer and MgCl2 concentrations
were adjusted in the primer reaction mixture to achieve amplification
of the highest sensitivity without primer-dimer formation. The reac-
tion mixture contained final amounts (for 100 ,l) of either SK38/39
(20 pmol each), SK29/30 (100 pmol each), or SK68/69 (50 pmol each),
in 10 mMTris-HCI (pH 8.3), 50 mMKC1, 1.5 mMMgCI2 (4.0 mM
with SK68/69 primers), 0.01% (wt/vol) gelatin, 0.2 mMof each de-
oxyribonucleoside triphosphate (dATP, dGTP, dCTP, and dTTP), and
2 units of recombinant Thermus aquaticus (Taq) polymerase (Perkin
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Elmer Corp., Norwalk, CT). All samples were added to the tubes with a
positive displacement pipetteman, and care was taken to prevent cross
contamination of samples. DNAlysates from seronegatives were used
as negative controls in every PCRreaction. The H9 human T cell line
infected persistently with HTLV-IIIb (ATCC CRL8543) was diluted
with uninfected cells 100-1,000-fold for use as the positive control in
each reaction. DNAamplification was performed in a Perkin-Elmer
thermal cycler for 30 cycles, programmed to denature for I min at
95°C, anneal for I min at 55°C, and extend for 1.5 min at 72°C. To
complete polymerization of the amplified products, a 10-min exten-
sion at 72°C was added at the end of the 30 cycles. PCRproducts were
stored at 4°C.
Hybridization of PCRproducts with HIV-I probes. Oligonucleotide
probes, derived from internally conserved sequences of the amplified
region, were used to detect the amplified products. These included
SK19 (gag), SK31 (LTR), and SK70 (env) (4). 35 pmol of each probe
was 5' labeled with radioactive 32-ATP (100 MCi) at 37°C for I h using
T4 polynucleotide kinase (Boehringer Mannheim Biochemicals). Un-
incorporated label was removed by elution over a Nensorb column
(NEN Dupont Products, Boston, MA).
The hybridization reaction contained 10 Ml PCRproduct and 5 Ml
probe mixture. The probe mixture consisted of 500,000 cpm of the
appropriate probe (I Ml), 150 mMNaCl (final concentration), and dis-
tilled H20. The samples were denatured at 95°C for 5 min and hybrid-
ized in solution for 10 min in a 56°C waterbath. The oligonucleotide
probe-target DNAheteroduplex was resolved by electrophoresis on a
10% polyacrylamide gel, operated at 200 V for 90 min. The charac-
teristic gel retardation fragment representing the amplified HIV-I se-
quences were visualized by autoradiography after exposure to XAR
film (Eastman Kodak Co., Rochester, NY) with one intensifying screen
for 2-4 h at -70°C.
Sensitivity and specificity of the PCRanalysis. Reaction conditions
of the PCRand hybridization allowed detection of amplified products
from HIV- I infected H9 cells (diluted with uninfected PBMC)at a level
< 5 cells per reaction. If no characteristic band was visualized, the
samples were considered negative. Samples were considered positive if
the characteristic gel retardation fragments were detected on the autora-
diogram at a moderate to high intensity relative to an undetectable to
weak intensity in the negative control.
Samples which failed to amplify with all HIV primer sets were am-
plified with oligonucleotide primer pairs (GH26 and GH27, 50 pmol
each) from a conserved region of the HLA-DQa locus (8) to determine
if the DNApresent in the lysate could be amplified. Amplified products
were resolved on a composite 3%NuSieve (FMC Bioproducts, Rock-
land, ME) and 1%agarose gel,.and visualized by ethidium bromide
staining. If PCRproducts were undetectable by this method, the sam-
ples were excluded from the study.
Results
The clinical parameters of the 23 HIV- 1 seropositive patients
are shown in Table I. The complete disease spectrum was repre-
sented among the group studied: 13 had no symptoms, 5 had
ARC, and 5 had AIDS. 10 patients had received AZT antiviral
therapy for at least 3 mobefore venipuncture. Peripheral blood
CD4/CD8 T cell ratios were typically decreased (< 1.0).
Efforts to prevent sample contamination were important
-for distinguishing true positives with the PCRtechnique. The
gag and more particularly the env primers were more likely to
generate false positive PCRproducts, which emphasizes the
Table L Clinical Parameters and PCRAnalysis of HI V-I Infection from 23 Seropositive Patients
Clinical Antiviral CD4/CD8 T cells Monocytes
Patient No. diagnosis treatment cells/pl gag/env/LTR* gag/env/LTR*
I ARC AZT 207/1960 +/+/- -/+/-
2 ASX AZT 1109/1357 +/+/- +/+/-
3 ASX 469/765 +/+/+ +/+/-
4 ARC 338/857 +/+/+ -/+/-
5 ASX 586/987 +/+/+ +/+/-
6 ASX 565/849 +/+/+ -/+/-
7 AIDS 172/560 +/+/- +/+/-
8 AIDS AZT/ZOV 643/580 +/+/- +/+/-
9 ASX 748/1016 +/+/+ +/+/-
10 AIDS 252/1189 +/-/+ +/+/-
11 ASX 675/1073 +/+/+
12 ARC AZT/ZOV 368/1233 +/+/-
13 ASX AZT/ZOV 639/826 +/-/-
14 AIDS AZT/ZOV 79/1215 +/-/-
15 ARC AZT 282/2270 +/+/-
16 ASX AL721 419/1100 +/+/+
17 ASX 397/761 +/+/+
18 ASX AZT/ZOV 283/742 +/+/+
19 ASX 741/1123 +/+/-
20 ASX 453/1424 +/+/+ +/+/+*
21 AIDS AZT/ZOV 204/974 +/+/+
22 ARC 240/525 +/+/+ +/+/+*
23 ASX 768/916 +/+/+ +/+/-
* DNAamplification with SK38/39 (gag), SK68/69 (env), and SK29/30 (LTR) primers and hybridization with SK19 (gag), SK70 (env), and
SK31 (LTR) probes, respectively. Signal detected by autoradiography after 2-4 h exposure. t Amplification with LTR primers detected by au-
toradiography after 18 h only.
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Figure 1. HIV-1 amplified pi
T cells and (B) monocytes frc
patient No. 18, ASX (lane 2)
Analysis of equal numbers of unstimulated blood T cells
and monocytes from the infected patients by DNAamplifica-
tion of HIV-specific sequences is shown in Table I. Amplified
HIV- I DNAwas detected in at least one primer in all patients'
T cells and in 21/23 patients' monocytes. If DNAamplification
with two primer sets is considered sufficient to confirm HIV- 1
infection, this occurred in 21 out of 23 (91%) patients' T cells
and in 17 out of 23 (74%) patients' monocytes. Monocyte ly-
SW _- 'Tsates but not T cell lysates from two patients (No. 12 and No.
lw 16), failed to amplify with HIV- 1 primers but did amplify with
the HLA primers GH26/27 (data not shown), and were there-
fore considered true negatives.
A typical example of the HIV- 1 amplified products with the
three primer sets detected by autoradiography is shown in Fig.
2 3 4 1 2 3 4 1. The signal was apparent in most cases after a 2-h exposure
b C and was confirmed after a 4-h exposure. When present, the
signal intensity was generally similar for the two cell types using
the gag and env primers and corresponding probes. The major-
ity of the T cell samples amplified with LTR primers. Only two
monocyte lysates amplified with the LTR primers; reaction
products were detected by autoradiography only after an 18-h
exposure, which suggests that the amplification may have oc-
curred in a few contaminating T cells.
To assess the relative number of infected cells per sample,
serial 10-fold dilutions of the DNAlysates from four patients
(Nos. 4, 18, 21, 22) with seronegative PBMClysates were pre-
_l. pared for PCR. Autoradiography of the hybridized products
from patients No. 21 and No. 22 is shown in Fig. 2, and the
pattern was similar for patients No. 4 and No. 18. PCRprod-
ucts were detectable to at least a 1,000-fold dilution (500 cells
out of 500,000) in both the T cell and monocyte samples in all
four patients.
2 3 4 1 2 3 4 PCR analysis was repeated 7-9 mo later in five patients
b C whose course of disease, CD4+T cells, or management had not
significantly changed, and the results are shown in Table II.
roducts detected by autoradiography. (A) HIV- I was detected again in all patients' T cells and in four out
)m patient No. 21 with AIDS (lane 1), of the five patients' monocytes, although there was some varia-
, patient No. 10 with AIDS (lane 3), and tion in amplification with individual primers.
patient No. 4 with ARC(lane 4). Amplification with primers (a)
SK68/69 (env), (b) SK38/39 (gag), and (c) SK29/30 (LTR). No
fragments were detected by amplification of monocyte DNAwith the
LTR primers (c).
need to include a negative control with each analysis. The LTR
primers were less sensitive but overall more specific in detect-
ing HIV- 1 infection, giving no false positives or primer-dimer
formation.
Discussion
DNAamplification with the PCRtechnique now affords the
opportunity to detect fewer than five copies of HIV- 1 DNAin
mononuclear cells. In our hands, there is some variability in
the detection of HIV- 1 by gag and env primers, which indicates
that at least two sets of primers should be used to confirm HIV
infection by the PCRmethod. It is not clear why the monocyte
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5
1 , I I, 1 __-I
A B C D
Figure 2. Amplification of 10-fold serial
dilutions of patient No. 21 (A, B) and patient
No. 22 (C, D) DNAlysates using the SK38/
39 primers and the SKI 9 end-labeled probe.
Autoradiography exposure: 3 h. (A, C) T
cells; (B, D) monocytes. (1) 5 x IO' cells; (2)
5 X 104 cells; (3) 5 x 103 cells; (4) 5 X 102
cells; (5) 5 x 10' cells.
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Table II. Repeat PCRAnalysis of Five Patients for Detection
of HIV-I Infection
T cells Monocytes
Patient No. gag/env/LTR gag/env/LTR
1 1) +/+/- 1 //
2) +/+/+ 2) -/+/-
3 1) +/+/+ 1) +/+/-
2) +/+/+ 2) +/+/-
13 1) +/-/- 1)
2) +/+/+ 2) -f-/-
17 1) +/+/+ 1)
2) +/+/+ 2) -/+/-
20 1) +/+/+ 1) +/+/+
2) +/+/+ 2) -/+/-
Data for the first venipuncture is the same as shown in Table I. The
second venipuncture was performed 7-9 mo later.
population failed to amplify with the LTR sequences (Table I,
Fig. 1), but we now wonder if these sequences may vary among
the various mononuclear cell types.
Wefound comparable levels of latent HIV-l infection in
the blood cells from 10 patients with early disease (CD4' T cell
counts > 500, Table I) as in those with more progressive dis-
ease. Also, AZT-treated individuals, like untreated individuals,
were found to have HIV- 1 infection in one or both cell types.
This finding using PCRanalysis is in agreement with other
studies measuring viral production (1, 9).
Our evidence is that latent infection with HIV- 1 occurs in
both T cells and monocytes. This is in contrast to Schnittman
et al. (5) who noted that T cells were the principal reservoir.
This may reflect differences in the techniques to prepare mono-
cytes. Schnittman et al. sorted with a MAb to the monocyte
antigen, CD14. It is possible that latently infected cells were not
successfully sorted. Monocytes frequently are lost from the
sample because of adherence or clumping during cell sorting
procedures, or the latently infected monocyte may have low
levels of CD14, an antigen which is subject to downregulation,
e.g., by exposure to lipopolysaccharide (Wright, S. W., personal
communication). Wedoubt that our monocytes, which were
enriched by plastic adherence after 1-2 d in culture, were signif-
icantly contaminated with T cells, because CD3' cells were not
detectable by FACSanalyses (data not shown), and because the
level of infection in our T and monocyte populations seemed
similar by dilution analysis (Fig. 2). Our findings regarding the
difficulty of eliciting a productive HIV-l infection from mono-
cytes relative to T cells (6) are similar those of others (5). Onthe
other hand, it may be important to learn to approach the latent
infection of the monocyte fraction, if one is to devise better
strategies to prevent the spread of HIV- I infection within and
between seropositive individuals.
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